Results 241 to 250 of about 55,045 (296)
The impact of menopausal hormone therapy on overall mortality – a comprehensive review
Climacteric, 2020 Menopausal hormone therapy (MHT) is indicated for menopausal symptom relief. However, MHT has also been shown to be beneficial for prevention of long-term estrogen deficiency sequelae including mortality. Based on a comprehensive literature review on MHT
Petra Stute
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Journal of Obstetrics and Gynaecology Canada, 2005
Although estrogen has been clinically available for more than 6 decades, women have been confused by different opinions regarding the risks and benefits of menopausal hormone therapy (HT), estrogen therapy (ET), and estrogen-progestin therapy (EPT).
Bhagu R, Bhavnani, Ronald C, Strickler
openaire +3 more sources
Although estrogen has been clinically available for more than 6 decades, women have been confused by different opinions regarding the risks and benefits of menopausal hormone therapy (HT), estrogen therapy (ET), and estrogen-progestin therapy (EPT).
Bhagu R, Bhavnani, Ronald C, Strickler
openaire +3 more sources
Menopausal hormone therapy and menopausal symptoms
Fertility and Sterility, 2014A majority of women will experience bothersome symptoms related to declining and/or fluctuating levels of estrogen during their menopausal transition. Vasomotor symptoms, vaginal dryness, poor sleep, and depressed mood have all been found to worsen during the menopausal transition.
Zain A, Al-Safi, Nanette, Santoro
openaire +2 more sources
Bleeding with menopausal hormone therapy
Best Practice & Research Clinical Obstetrics & Gynaecology, 2009Hormone therapy is highly effective for the treatment of menopausal vasomotor symptoms and vaginal dryness, but commonly leads to unscheduled vaginal bleeding and spotting. This frequently leads to invasive investigations to exclude underlying malignancy and is also very unpopular amongst users.
Martha, Hickey, Sweta, Agarwal
openaire +2 more sources
Update on menopausal hormone therapy
Current Opinion in Endocrinology, Diabetes & Obesity, 2015Menopause management has undergone an eventful journey over the past decade; some dogmas got refuted, some new hypotheses took life, and the review is timely and relevant to the practice of clinical medicine in 2015.The field stepped out of an era of absolutes into times of patient centeredness and an individualized perspective.The onus now is to ...
Tugba Altun, Ensari, Lubna, Pal
openaire +2 more sources
2020
As longevity expands, women are spending a third of their existence in menopause and beyond. The vast majority suffer from symptoms that negatively impact their quality of life. Systemic vasomotor symptoms (VMS) are the classic cluster affecting 80% of peri- and post-menopausal women.
openaire +2 more sources
As longevity expands, women are spending a third of their existence in menopause and beyond. The vast majority suffer from symptoms that negatively impact their quality of life. Systemic vasomotor symptoms (VMS) are the classic cluster affecting 80% of peri- and post-menopausal women.
openaire +2 more sources
Menopause, hormone therapy and diabetes
Climacteric, 2017Over the past three decades, the prevalence of diabetes has increased four-fold. Coupled with the global obesity epidemic and aging of the world's population, a perfect metabolic storm is brewing. The influence of menopause and exogenous estrogen and progestogens must be included in this equation.
openaire +2 more sources
Hormone Therapy: Menopausal Hormone Therapy.
FP essentials, 2023The marked decrease in estrogen levels in menopausal women can cause bothersome symptoms that affect daily life. More than 75% of women experience menopausal symptoms, which can include vaginal dryness, itching, discharge, dyspareunia, mood changes, hot flushes, and night sweats.
openaire +1 more source